A citation-based method for searching scientific literature

Tao Zu, Lisa A Duvick, Michael D Kaytor, Michael S Berlinger, Huda Y Zoghbi, H Brent Clark, Harry T Orr. J Neurosci 2004
Times Cited: 190



Juan Crespo-Barreto, John D Fryer, Chad A Shaw, Harry T Orr, Huda Y Zoghbi. PLoS Genet 2010
Times Cited: 85




List of shared articles



Times cited

Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.
Jan Cendelin, Marija Cvetanovic, Mandi Gandelman, Hirokazu Hirai, Harry T Orr, Stefan M Pulst, Michael Strupp, Filip Tichanek, Jan Tuma, Mario Manto. Cerebellum 2021
0

Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain.
Megan S Keiser, Paul T Ranum, Carolyn M Yrigollen, Ellie M Carrell, Geary R Smith, Amy L Muehlmatt, Yong Hong Chen, Joel M Stein, Ronald L Wolf, Enrico Radaelli,[...]. Nat Med 2021
0

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion.
Anna Niewiadomska-Cimicka, Antoine Hache, Yvon Trottier. Front Neurosci 2020
6


Spinocerebellar ataxias: prospects and challenges for therapy development.
Tetsuo Ashizawa, Gülin Öz, Henry L Paulson. Nat Rev Neurol 2018
77

Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.
Sofia Esteves, Sara Duarte-Silva, Patrícia Maciel. Med Res Rev 2017
12

Impaired mTORC1-Dependent Expression of Homer-3 Influences SCA1 Pathophysiology.
Céline Ruegsegger, David M Stucki, Silvio Steiner, Nico Angliker, Julika Radecke, Eva Keller, Benoît Zuber, Markus A Rüegg, Smita Saxena. Neuron 2016
21



RNA therapy for polyglutamine neurodegenerative diseases.
Lauren M Watson, Matthew J A Wood. Expert Rev Mol Med 2012
10